We are live on ! Find out more
RWJF

Robert Wood Johnson Foundation Portfolio holdings

AUM $81M
1-Year Est. Return 0.47%
This Fund
S&P 500
This Quarter Est. Return
+7.58%
1 Year Est. Return
+0.47%
3 Year Est. Return
-4.83%
5 Year Est. Return
-4.4%
10 Year Est. Return
-8.06%
AUM
$6.88B
AUM Growth
+$3.68B
Cap. Flow
+$212M
Cap. Flow %
3.08%
Top 10 Hldgs %
100%
Holding
3
New
1
Increased
1
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
RPRX icon
Royalty Pharma
RPRX
+$197M
2
OBDC icon
Blue Owl Capital
OBDC
+$15.3M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 54.63%
2 Financials 45.37%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
OBDC icon
1
Blue Owl Capital
OBDC
$5.62B
$3.12B 45.37%
2,530,929
+1,235,627
+95% +$15.3M
RPRX icon
2
Royalty Pharma
RPRX
$28.5B
$1.93B 28.05%
+3,973,800
New +$197M
JNJ icon
3
Johnson & Johnson
JNJ
$663B
$1.83B 26.58%
13,000,000
– –

Similar funds

RCI
Ridgeback Capital Investments Miami Beach, Florida $80.9M AUM
CLP
Charis Legacy Partners Bryan, Texas $81.3M AUM 30.13% 1-Year Est. Return
PA
ProCore Advisors Newport Beach, California $80.7M AUM
RC
Rithm Capital New York $81.4M AUM 48.8% 1-Year Est. Return
LTM
Lotus Technology Management Orlando, Florida $81.5M AUM
NVIM
New Vernon Investment Management Highland Park, Illinois $81.7M AUM 8.29% 1-Year Est. Return
MM
MQS Management New York $81.9M AUM 2.99% 1-Year Est. Return
BG
BRX Global New York $81.9M AUM 16.22% 1-Year Est. Return

Robert Wood Johnson Foundation's Q2 2020 Portfolio in Review

As of Q2 2020, Robert Wood Johnson Foundation held 3 positions worth $6.88B, up 115% from $3.2B the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Robert Wood Johnson Foundation deployed $212M of net new capital in Q2 2020, opening 1 new position and adding to 1 existing holding. Its largest new stake was Royalty Pharma: 3,973,800 shares worth $1.93B.

By sector, the portfolio is most concentrated in Healthcare at 55% of assets, up from 53% a quarter earlier, followed by Financials.

  • Robert Wood Johnson Foundation's largest Q2 2020 buy was Royalty Pharma: 3,973,800 shares worth $1.93B.
  • Robert Wood Johnson Foundation added most to Blue Owl Capital in Q2 2020, an estimated $15.3M increase.
  • Robert Wood Johnson Foundation's ten largest holdings make up 100% of its $6.88B portfolio in Q2 2020.
  • Robert Wood Johnson Foundation opened 1 new position and closed 0 in Q2 2020.
  • Robert Wood Johnson Foundation's portfolio value rose 115% quarter-over-quarter to $6.88B.

Based on Robert Wood Johnson Foundation's 13F filing for Q2 2020, filed 6 Aug 2020.